NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial
在老年初治转移性胰腺癌患者中,NALIRIFOX 与白蛋白结合型紫杉醇联合吉西他滨的疗效比较:一项关键性 NAPOLI 3 试验的亚组分析
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106043
Macarulla, T; Cid, R Pazo; Womack, M S; Gracian, A Cubillo; Zervoudakis, A; Hatoum, H; Chung, V; Patel, A; Paulson, A S; Pant, S; O'Reilly, E M; Hubner, R A; Van Cutsem, E; Bekaii-Saab, T; Zhang, L; Li, J; Chen, H; Maxwell, F; Wainberg, Z A; Melisi, D